Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

about

Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitations.

P2860

Q47595482-A6DB1A0D-E973-434B-AAB1-4DD3F6DD8E24

P2860

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q43885735

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@en

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@nl

type

Item

label

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@en

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@nl

prefLabel

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@en

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@nl

P1476

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

@en

P2093

Arai H

http://www.w3.org/2001/XMLSchema#string

Maruyama M

http://www.w3.org/2001/XMLSchema#string

Matsui T

http://www.w3.org/2001/XMLSchema#string

Sasaki H

http://www.w3.org/2001/XMLSchema#string

Sugita M

http://www.w3.org/2001/XMLSchema#string

Tanji H

http://www.w3.org/2001/XMLSchema#string

Yoshida H

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Statins and the risk of dementia.

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans.

P304

1738-1739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1532-5415.2001.49293.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nobuyuki Okamura

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11844016

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

about

P2860

P2860

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921